Novel insights into targeting ATP-binding cassette transporters for antitumor therapy

L Gatti1, G Cossa, G L Beretta

  • 1Molecular Pharmacology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, via Amadeo 42, 20133 Milan, Italy.

Insights

ATP-binding cassette (ABC) transporters help cancer cells resist drugs. Understanding how these transporters are regulated, including by microRNAs, can lead to new ways to improve cancer treatment efficacy.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • ATP-binding cassette (ABC) transporters are proteins involved in cellular functions.
  • Specific ABC transporters mediate the efflux of cytotoxic and targeted antitumor drugs from cells.
  • Emerging evidence suggests ABC transporters influence tumor cell survival through mechanisms beyond drug efflux.

Purpose of the Study:

  • To review the biological roles of ABC transporters in tumor cell resistance, including in cancer stem cells.
  • To highlight the need for further research into the regulatory mechanisms of ABC transporter function, such as posttranslational modifications and microRNA regulation.
  • To explore the potential of targeting ABC transporters to enhance the efficacy of anticancer therapies.

Main Methods:

  • Review of preclinical systems and cancer stem cell models.
  • Analysis of molecular mechanisms regulating ABC transporter expression and function.
  • Synthesis of current knowledge on ABC transporters in drug resistance.

Main Results:

  • ABC transporters play a significant role in mediating resistance in various tumor cells, including cancer stem cells.
  • Regulation of ABC transporter levels, potentially via microRNAs and posttranslational modifications, is critical but not fully understood.
  • Preclinical and cancer stem cell models indicate that ABC transporters are viable targets for modulating anticancer drug efficacy.

Conclusions:

  • ABC transporters are key mediators of multidrug resistance in cancer.
  • Further elucidation of ABC transporter regulation is crucial for developing novel therapeutic strategies.
  • Targeting ABC transporters holds promise for overcoming drug resistance and improving outcomes in cancer therapy.

Related Concept Videos

ABC Transporters: Exporter01:31

ABC Transporters: Exporter

ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
ABC Transporters: Importer01:27

ABC Transporters: Importer

ATP-binding cassette or ABC transporters are a class of ATP-driven pumps that hydrolyze ATP to move solutes across the membrane. They can be grouped into importers and exporters. While exporters are present in all domains of life, importers exist only in bacteria and some plants.
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...